Interventions for the prevention of recurrent erysipelas and cellulitis.
Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E, Leibovici L, Paul M.
Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD009758. doi: 10.1002/14651858.CD009758.pub2.
PMID:28631307
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS.
Risk factors for developing upper limb cellulitis after breast cancer treatment.
Engin O, Sahin E, Saribay E, Dilek B, Akalin E.
Lymphology. 2022;55(2):77-83.
PMID:36170582
COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
Lindgren AL, Austin AH, Welsh KM.
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211024431. doi: 10.1177/21501327211024431.
PMID:34120504
Surgical Lymphedema Treatment: A Meta-Analysis and Recommendations.
Chun MJ, Saeg F, Miller D, Jardak C, Duplechain A, Sultan A, Homsy C.
Eplasty. 2022 Nov 2;22:e51. eCollection 2022.
PMID:37026036
Longitudinal impact of postmastectomy radiotherapy on arm lymphedema in patients with breast cancer: An analysis of serial changes in arm volume measured by infrared optoelectronic volumetry.
Kim N, Kim H, Hwang JH, Park W, Cho WK, Yeo SM, Lee H, Lee SK.
Radiother Oncol. 2021 May;158:167-174. doi: 10.1016/j.radonc.2021.02.033. Epub 2021 Mar 3.
PMID:33667586
Liposuction gives complete reduction of chronic large arm lymphedema after breast cancer.